None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Qualified for the DES implantation ? Above the age of 19 ? Signed the consent form for participation in this research study voluntarily and agreed on the procedures to be followed during the clinical trial.
Exclusion criteria
Exclusion criteria: ? Implanted other DES product on the target lesion area ? Restricted from coronary angiography (ex. severe symptoms of heart failure.) ? Allergic reaction or intolerance to dual antiplatelet therapy (DAPT) ? Expected lifespan of less than one year with concurrent disorder/s. ? Pregnancy and lactation (or plan to give birth in near future)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major Adverse Cardiac Events : Cardiac Death, Myocardial Infarction, Stent Thrombosis, Target lesion revascularization | — |
Secondary
| Measure | Time frame |
|---|---|
| in stent late loss;in segment late loss;TVR(target vessel revasculirization) | — |
Countries
Korea, Republic of
Contacts
Gachon University Gil Medical Center